The Patent Finder

Terms ending in 2043

Schrödinger, Inc.

Every in-force patent on Schrödinger, Inc.'s record whose computed term ends in 2043, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 12,715,876Cyclic Compounds and Methods of Using Same
In force
 · High confidence
Schrödinger, Inc.In forceHigh confidence
US 12,686,688Heterocyclic Pericondensed CDC7 Kinase Inhibitors for the Treatment of Cancer
In force
 · High confidence
Schrödinger, Inc.In forceHigh confidence
US 12,667,572Tricyclic Compounds Useful in the Treatment of Cancer, Autoimmune and Inflammatory Disorders
In force
 · High confidence
Schrödinger, Inc.In forceHigh confidence
US 12,774,274Heterocyclic Compounds and Methods of Use
In force
 · High confidence
Schrödinger, Inc.In forceHigh confidence
4 of 4 patents shown. Soonest term end first, then patent number.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited